Asia-Pacific enterprise content management (ECM) market was valued at $14.4 billion in 2025 and is growing at a CAGR of 11.1% during the forecast period (2026-2035). The Asia-Pacific ECM market is witnessing rapid evolution as organizations increasingly prioritize digital transformation and efficient information governance. Businesses across the region are moving away from traditional paper-based workflows toward centralized digital content systems that enable real-time collaboration and secure data access. The rise of cloud adoption, coupled with advanced AI-powered document management tools, is reshaping how enterprises store, retrieve, and analyze critical business information. Sectors such as finance, healthcare, and government are particularly driving demand for ECM solutions that enhance compliance, reduce operational risks, and support remote workforce productivity.

Asia-Pacific data center interconnect (DCI) market was valued at $4.7 billion in 2025 and is growing at a CAGR of 12.5% during the forecast period (2026-2035). The Asia-Pacific data center interconnect (DCI) market is experiencing rapid growth as enterprises and cloud providers expand their digital infrastructure across the region. Increasing adoption of cloud computing, edge deployments, and multi-cloud strategies is driving demand for high-speed, low-latency connectivity between data centers. Countries such as China, India, Japan, and Singapore are seeing a surge in hyperscale and enterprise data center developments, creating a strong need for reliable interconnect solutions that support seamless data transfer and operational resilience.

Global artificial intelligence (AI) in healthcare market was valued at $19.8 billion in 2025 and is growing at a CAGR of 21.4% during the forecast period (2026-2035). The global AI in healthcare market reflects a paradigm shift in how care is delivered, with technologies increasingly embedded in diagnostics, patient engagement, and administrative workflows. AI systems are being used to parse complex clinical data, improve early disease detection, and automate routine tasks, enabling providers to focus more on direct patient care. Advanced tools such as virtual health assistants and predictive models are enhancing patient interaction, personalizing care plans, and supporting decision-making processes across clinical settings.

Global ultrasound market was valued at $7.4 billion in 2025 and is growing at a CAGR of 5.7% during the forecast period (2026-2035). Regulatory approvals for AI-enabled cardiac imaging solutions are strengthening trust in software-assisted ultrasound technologies among healthcare providers. This growing regulatory validation is encouraging hospitals and health systems to integrate AI-guided workflows into routine diagnostic and point-of-care ultrasound practices. As a result, ultrasound adoption is expanding beyond traditional imaging departments into decentralized care settings, supporting higher procedure volumes and broader end-user participation. These developments are contributing to the sustained growth of the global ultrasound market by improving device utilization, addressing workforce constraints, and enhancing diagnostic consistency. For instance, in January 2026, UltraSight received FDA clearance to expand its AI-guided Echo Stewardship Platform, enabling compatibility with various ultrasound systems, including handheld and cart-based devices. 

Global surface disinfectant market was valued at $4.5 billion in 2025 and is growing at a CAGR of 4.6% during the forecast period (2026-2035). Oxidizing agents play an essential role in surface disinfectants by effectively eliminating a broad spectrum of microorganisms, including bacteria, viruses, and fungi. These compounds, such as hydrogen peroxide, peracetic acid, and chlorine-based chemicals, work by disrupting the cellular components of pathogens through oxidation, leading to their inactivation. Their strong antimicrobial activity makes them suitable for high-risk environments like hospitals, laboratories, and pharmaceutical facilities. Oxidizing disinfectants are valued for their rapid action, minimal residue, and ability to reduce cross-contamination. They are often formulated in liquids, sprays, or wipes to provide versatile, reliable surface hygiene across diverse applications.

Global smartwatch market was valued at $40.7 billion in 2025 and is growing at a CAGR of 8.0% during the forecast period (2026-2035). Smartwatches play a significant role in medical and health monitoring by providing continuous, real-time tracking of key physiological parameters. They measure heart rate, blood oxygen levels, sleep patterns, and stress indicators, enabling users to gain insights into their overall well-being. Advanced models offer electrocardiogram (ECG) and irregular heartbeat detection, assisting in early identification of potential health issues. Integration with mobile health apps allows data storage, trend analysis, and sharing with healthcare providers. By combining convenience with proactive monitoring, smartwatches support preventive care, encourage healthier lifestyles, and empower individuals to make informed decisions about their health.

Sleep aid market was valued at $48.5 billion in 2025 and is growing at a CAGR of 6.1% during the forecast period (2026-2035). Growing recognition of sleep disorders, coupled with rising stress levels worldwide, is fueling the demand for more effective insomnia treatments, thereby driving the expansion of the sleep aid market. In line with this trend, pharmaceutical companies are increasingly focusing on developing novel therapies that target the underlying mechanisms of sleep regulation. For instance, in August 2025, Eisai launched its in-house developed anti-insomnia drug DAYVIGO (lemborexant) in China for treating adults with insomnia, impacting sleep onset and maintenance. DAYVIGO is a dual orexin receptor antagonist, acting by competitively binding to OX1R and OX2R receptors, regulating sleep-wake rhythm differently than conventional treatments like benzodiazepines. 

Global protein engineering market was valued at $3.5 billion in 2025 and is growing at a CAGR of 16.4% during the forecast period (2026-2035). Increasing investments in R&D for monoclonal antibodies, engineered proteins, and next-generation biologics are driving market growth and fueling demand for efficient protein engineering solutions. Additionally, this trend is reflected in recent funding activities that support the development of integrated, in-house protein engineering and validation capabilities aimed at accelerating antibody and biologics discovery. For instance, in January 2026, Nuclera successfully extended its Series C funding to a total of $87 million, including an additional $12 million financing extension aimed at enhancing its eProtein Discovery capabilities for antibody engineering. The funding, led by Elevage Medical Technologies and Jonathan Milner, 

Global Probiotics market was valued at $76.2 billion in 2025 and is growing at a CAGR of 8.2% during the forecast period (2026-2035). Probiotics are live microorganisms that, when consumed in adequate amounts, support the balance of beneficial bacteria in the human body, particularly in the digestive system. They are commonly incorporated into foods, beverages, and dietary supplements due to their association with digestive health and overall well-being. Probiotics function by helping maintain microbial balance, supporting normal gut function, and contributing to the body’s natural defense mechanisms. Their use has expanded beyond traditional dairy products into a wider range of food and beverage formats, reflecting changing consumer preferences and advancements in formulation and storage technologies. Probiotic-enriched dairy products dominate the market due to high consumer demand for gut health, digestive benefits, and overall wellness. For instance,

Global power bank market was valued at $14.0 billion in 2025 and is growing at a CAGR of 6.1% during the forecast period (2026-2035). Growing deployment of utility-scale renewable technologies, including solar, battery energy storage, and hybrid projects, is revealing a heightened necessity for interconnection deposits, which in turn necessitates structured financing solutions to effectively progress projects through development pipelines, thereby driving market growth. This trend is increasingly reflected in recent financing arrangements within the renewable energy development ecosystem, where dedicated capital is being used to address upfront interconnection requirements and accelerate project advancement. For instance, in December 2025, $8 million loan secured by PowerBank will fund interconnection deposits for a portfolio of 34 MW of solar power, battery energy storage, and hybrid projects.